1. Neuronal Signaling Protein Tyrosine Kinase/RTK
  2. Trk Receptor
  3. GNF-5837

GNF-5837 is a potent, selective, and orally bioavailable pan-tropomyosin receptor kinase (TRK) inhibitor which display antiproliferative effects in cellular Ba/F3 assays ( IC50 values of 7 nM, 9 nM and 11 nM for cells containing the fusion proteins Tel-TrkC, Tel-TrkB and Tel-TrkA, respectively) .

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

GNF-5837

GNF-5837 構造式

CAS 番号 : 1033769-28-6

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 65 在庫あり
Solution
10 mM * 1 mL in DMSO USD 65 在庫あり
Solid
5 mg $55 在庫あり
10 mg $99 在庫あり
25 mg $165 在庫あり
50 mg $264 在庫あり
100 mg $440 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 4 publication(s) in Google Scholar

Top Publications Citing Use of Products

Trk Receptor アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

GNF-5837 is a potent, selective, and orally bioavailable pan-tropomyosin receptor kinase (TRK) inhibitor which display antiproliferative effects in cellular Ba/F3 assays ( IC50 values of 7 nM, 9 nM and 11 nM for cells containing the fusion proteins Tel-TrkC, Tel-TrkB and Tel-TrkA, respectively) [1].

IC50 & Target[1]

TrkB

9 nM (IC50)

TrkC

7 nM (IC50)

TrkA

11 nM (IC50)

Cellular Effect
Cell Line Type Value Description References
A10 IC50
0.5 μM
Compound: 22, GNF-5837
Inhibition of PDGFR in rat A10 cells
Inhibition of PDGFR in rat A10 cells
[PMID: 24900443]
BaF3 IC50
0.007 μM
Compound: 22, GNF-5837
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKC
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKC
[PMID: 24900443]
BaF3 IC50
0.009 μM
Compound: 22, GNF-5837
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKB
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKB
[PMID: 24900443]
BaF3 IC50
0.011 μM
Compound: 22, GNF-5837
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKA
Antiproliferative activity against mouse BA/F3 cells expressing Tel-TRKA
[PMID: 24900443]
BaF3 IC50
0.042 μM
Compound: 22, GNF-5837
Antiproliferative activity against mouse BA/F3 cells expressing TRKA and NGF
Antiproliferative activity against mouse BA/F3 cells expressing TRKA and NGF
[PMID: 24900443]
BaF3 IC50
0.87 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused PDGFRbeta in mouse BA/F3 cells
Inhibition of Tel-fused PDGFRbeta in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
0.91 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused KIT in mouse BA/F3 cells
Inhibition of Tel-fused KIT in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
2.9 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused JNK2 in mouse BA/F3 cells
Inhibition of Tel-fused JNK2 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
3 μM
Compound: 22, GNF-5837
Antiproliferative activity against mouse BA/F3 cells expressing Tel-KDR
Antiproliferative activity against mouse BA/F3 cells expressing Tel-KDR
[PMID: 24900443]
BaF3 IC50
3.4 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused ALK in mouse BA/F3 cells
Inhibition of Tel-fused ALK in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
3.6 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FGR in mouse BA/F3 cells
Inhibition of Tel-fused FGR in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
4 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FMS in mouse BA/F3 cells
Inhibition of Tel-fused FMS in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
4.4 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FLT1 in mouse BA/F3 cells
Inhibition of Tel-fused FLT1 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
4.7 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused RON in mouse BA/F3 cells
Inhibition of Tel-fused RON in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
4.7 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused ZAP70 in mouse BA/F3 cells
Inhibition of Tel-fused ZAP70 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.1 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FLT3 in mouse BA/F3 cells
Inhibition of Tel-fused FLT3 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.3 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused RET in mouse BA/F3 cells
Inhibition of Tel-fused RET in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.6 μM
Compound: 22, GNF-5837
Antiproliferative activity against wild type mouse BA/F3 cells in presence of IL3
Antiproliferative activity against wild type mouse BA/F3 cells in presence of IL3
[PMID: 24900443]
BaF3 IC50
5.7 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused TIE1 in mouse BA/F3 cells
Inhibition of Tel-fused TIE1 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.8 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused EPHB2 in mouse BA/F3 cells
Inhibition of Tel-fused EPHB2 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.8 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused MET in mouse BA/F3 cells
Inhibition of Tel-fused MET in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
5.9 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused EPHA3 in mouse BA/F3 cells
Inhibition of Tel-fused EPHA3 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
6 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused ROS in mouse BA/F3 cells
Inhibition of Tel-fused ROS in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
6.7 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused BMX in mouse BA/F3 cells
Inhibition of Tel-fused BMX in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
6.8 μM
Compound: 22, GNF-5837
Inhibition of NMP-ALK in mouse BA/F3 cells
Inhibition of NMP-ALK in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
7 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FGFR4 in mouse BA/F3 cells
Inhibition of Tel-fused FGFR4 in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
7.3 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused LYN in mouse BA/F3 cells
Inhibition of Tel-fused LYN in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
7.3 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused SRC in mouse BA/F3 cells
Inhibition of Tel-fused SRC in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
7.6 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused IGF1R in mouse BA/F3 cells
Inhibition of Tel-fused IGF1R in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
8 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused INSR in mouse BA/F3 cells
Inhibition of Tel-fused INSR in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
8.2 μM
Compound: 22, GNF-5837
Inhibition of Bcr-ABL in mouse BA/F3 cells
Inhibition of Bcr-ABL in mouse BA/F3 cells
[PMID: 24900443]
BaF3 IC50
9.3 μM
Compound: 22, GNF-5837
Inhibition of Tel-fused FGFR3 in mouse BA/F3 cells
Inhibition of Tel-fused FGFR3 in mouse BA/F3 cells
[PMID: 24900443]
体外実験

GNF-5837 (0.1-500 nM; 72-144 hours; GOT1 cells) treatment decreases cell viability in a time- and dose-dependent manner in GOT1 cells[2].
? GNF-5837 (5-500 nM; 24 hours; GOT1 cells) causes downregulation of PI3K-Akt-mTOR signaling, Ras-Raf-MEK-ERK signaling[2].
? GNF-5837 (5-500 nM; 72 hours; GOT1 cells) treatment induces G1 cell cycle arrest[2].
? GNF-5837 (500 nM; 144 hours; GOT1 cells) treatment increases apoptotic cell death[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: GOT1 cells
Concentration: 0.1 nM , 0.5 nM , 1 nM , 5 nM , 10 nM , 50 nM , 100 nM and 500 nM
Incubation Time: 72 hours, 96 hours and 144 hours
Result: Cell viability assay determined a clear decrease of GOT1 cell viability in a time- and dose- dependent manner.

Western Blot Analysis[2]

Cell Line: GOT1 cells
Concentration: 5 nM, 50 nM and 500 nM
Incubation Time: 24 hours
Result: Significant levels of TrkA expression, faint TrkC expression and no TrkB expression.

Cell Cycle Analysis[2]

Cell Line: GOT1 cells
Concentration: 5 nM, 500 nM
Incubation Time: 72 hours
Result: Induced G1 cell cycle arrest.

Apoptosis Analysis[2]

Cell Line: GOT1 cells
Concentration: 500 nM
Incubation Time: 144 hours
Result: Induced apoptosis.
体内実験

GNF-5837 (25-100 mg/kg; oral administration; once daily; for 10 days; mice) treatment inhibits tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mouse xenograft model[1]
Dosage: 25 mg/kg, 50 mg/kg, 100 mg/kg
Administration: Oral administration; once daily; for 10 days
Result: 72 and 100% tumor regression was observed at 50 and 100 mg/kg, respectively. At 25 mg/kg, only partial tumor growth inhibition was achieved.
分子量

535.49

分子式

C28H21F4N5O2

CAS 番号
Appearance

Solid

Color

Orange to red

SMILES

O=C(NC1=CC(C(F)(F)F)=CC=C1F)NC2=CC=C(C)C(NC3=CC(NC/4=O)=C(C=C3)C4=C\C5=CC=CN5)=C2

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
溶剤 & 溶解度
体外: 

DMSO : ≥ 32 mg/mL (59.76 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.8674 mL 9.3372 mL 18.6745 mL
5 mM 0.3735 mL 1.8674 mL 3.7349 mL
10 mM 0.1867 mL 0.9337 mL 1.8674 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (4.67 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: 2.5 mg/mL (4.67 mM); Suspended solution; Need ultrasonic

    This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション

純度: 99.44%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.8674 mL 9.3372 mL 18.6745 mL 46.6862 mL
5 mM 0.3735 mL 1.8674 mL 3.7349 mL 9.3372 mL
10 mM 0.1867 mL 0.9337 mL 1.8674 mL 4.6686 mL
15 mM 0.1245 mL 0.6225 mL 1.2450 mL 3.1124 mL
20 mM 0.0934 mL 0.4669 mL 0.9337 mL 2.3343 mL
25 mM 0.0747 mL 0.3735 mL 0.7470 mL 1.8674 mL
30 mM 0.0622 mL 0.3112 mL 0.6225 mL 1.5562 mL
40 mM 0.0467 mL 0.2334 mL 0.4669 mL 1.1672 mL
50 mM 0.0373 mL 0.1867 mL 0.3735 mL 0.9337 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
GNF-5837
製品番号:
HY-13491
数量:
MCE 日本正規代理店: